Lila Bio wins $3.65M NIH SBIR grant to build AI-designed proteins for pulmonary hypertension

Lila Bio won a $3.65 million NIH SBIR fast-track grant to develop AI-designed therapeutic proteins for pulmonary hypertension, receiving an initial $605,981 phase followed by $3,049,462 in a second phase. The Seattle startup, founded in 2023 by Jake Kraft and Anindya Roy, previously raised a $10 million seed round and will use the non-dilutive funding to advance candidates toward clinical utility.

More: Best Technologies, GeekWire

No comments yet.